Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :61
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: A retrospective analysis

Thota N K, Gundeti S, Linga V G, Coca P, Tara R P, Raghunadharao

Year : 2014| Volume: 51| Issue : 1 | Page no: 5-9

   This article has been cited by
1 CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels
Yuming Pan,Jin Lou,Heng Wang,Na An,Huan Chen,Qiaoxia Zhang,Xin Du
Blood Cells, Molecules, and Diseases. 2018; 73: 38
[Pubmed]  [Google Scholar] [DOI]
2 Chronic Myeloid Leukemia in India
Prasanth Ganesan,Lalit Kumar
Journal of Global Oncology. 2017; 3(1): 64
[Pubmed]  [Google Scholar] [DOI]
3 Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting
Blaise Felix Faye,Nata Dieng,Moussa Seck,Macoura Gadji,Youssou Bamar Gueye,Diariatou Sy,Sokhna Aissatou Toure,Abibatou Sall,Awa Oumar Toure,Tandakha Ndiaye Dieye,Saliou Diop
Annals of Hematology. 2016; 95(10): 1603
[Pubmed]  [Google Scholar] [DOI]
4 Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure
Jennifer Whiteley,Arlene Reisman,Mark Shapiro,JorgeE. Cortes,David Cella
Current Medical Research and Opinion. 2016; 32(8): 1325
[Pubmed]  [Google Scholar] [DOI]
5 Imatinib
Reactions Weekly. 2015; 1574(1): 136
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow